Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projekte/516-phase-iii-international-randomized-study-of-trabectedin-plus-pegylated-liposomal-doxorubicin-pld-versus-car-boplatin-plus-pld-in-patients-with-ovarian-cancer-progress-ing-within-6-12-months-of-last-platinum